Alpha Crest Capital Management LLC Veracyte, Inc. Transaction History

Alpha Crest Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$36.09 - $53.79 $525,217 - $782,805	-14,553 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$35.62 - $52.97 $518,377 - $770,872	14,553 New	14,553 $676,000
Q1 2021 May 13, 2021	SELL	$44.47 - $81.38 $420,374 - $769,285	-9,453 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$32.49 - $61.88 $69,756 - $132,856	-2,147 Reduced 18.51%	9,453 $463,000
Q3 2020 Nov 12, 2020	BUY	$26.73 - $35.67 $49,370 - $65,882	1,847 Added 18.94%	11,600 $377,000
Q2 2020 Aug 12, 2020	SELL	$19.49 - $28.11 $242,592 - $349,885	-12,447 Reduced 56.07%	9,753 $253,000
Q1 2020 May 13, 2020	BUY	$16.13 - $30.17 $238,723 - $446,516	14,800 Added 200.0%	22,200 $540,000
Q4 2019 Feb 12, 2020	BUY	$20.78 - $29.99 $153,772 - $221,926	7,400 New	7,400 $207,000

307

81.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.